Prostatis Group’s iShares Convertible Bond ETF ICVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,799
Closed -$317K 65
2022
Q1
$317K Buy
3,799
+2
+0.1% +$166 0.25% 54
2021
Q4
$339K Sell
3,797
-304
-7% -$29.6K 0.21% 64
2021
Q3
$409K Sell
4,101
-206
-5% -$20.7K 0.24% 65
2021
Q2
$439K Sell
4,307
-2,643
-38% -$262K 0.3% 61
2021
Q1
$683K Sell
6,950
-13,283
-66% -$1.36M 0.54% 50
2020
Q4
$1.95M Buy
20,233
+827
+4% +$73.2K 1.64% 15
2020
Q3
$1.57M Buy
19,406
+11,903
+159% +$928K 1.48% 20
2020
Q2
$532K Sell
7,503
-2,018
-21% -$128K 1.07% 33
2020
Q1
$518K Buy
9,521
+3,436
+56% +$213K 0.74% 24
2019
Q4
$382K Buy
+6,085
New +$366K 0.34% 58

Other funds holding ICVT

Prostatis Group's ICVT Position: Q2 2022 in Review

Prostatis Group sold out of iShares Convertible Bond ETF (ICVT) in Q2 2022, closing a stake of 3,799 shares — an estimated $317K sold.

Prostatis Group first reported a position in ICVT in Q4 2019 and held it in 10 quarters. The position peaked at $1.95M in Q4 2020. 283 funds tracked by Wall St. Rank hold ICVT as of Q2 2022.

  • Prostatis Group reported no remaining iShares Convertible Bond ETF position as of Q2 2022 after selling out during the quarter.
  • Prostatis Group sold 3,799 iShares Convertible Bond ETF shares in Q2 2022, an estimated $317K.
  • Prostatis Group first reported a position in iShares Convertible Bond ETF in Q4 2019 and held it in 10 quarters.
  • Prostatis Group's iShares Convertible Bond ETF position peaked at $1.95M in Q4 2020.
  • 283 funds tracked by Wall St. Rank held iShares Convertible Bond ETF as of Q2 2022.

Based on Prostatis Group's 13F filing for Q2 2022, filed 23 Mar 2023.